AIDS prevention gel studies halted

updated 1:55 p.m. ET Jan. 31, 2007

Researchers have halted two studies of a vaginal microbicide in Africa and India that doctors had hoped would prevent HIV infection after results suggested the gel might raise rather than lower that risk.

The results are “a disappointing and unexpected setback” to efforts to get a simple tool that women could use to lower their risk of getting the AIDS virus from sex, said a statement from the World Health Organization.

The large, final-stage experiments were in parts of Africa and India. More than half of all new infections with the AIDS virus in Africa involve women and girls, and scientists have long sought a method they could use, even without their partners’ knowledge, to reduce risk because many men refuse to use condoms.

The studies were testing Ushercell, a gel containing cellulose sulfate, a cotton-based compound developed by Polydex Pharmaceuticals, based in Toronto.

One study involving 1,500 women in South Africa, Benin, Uganda and India was stopped this week after an independent safety monitoring board saw more HIV infections among women using the gel than those given a dummy medication. The study was led by CONRAD, a Virginia-based health research group, and paid for by USAID and the Bill & Melinda Gates Foundation.

The second study of Ushercell, by Family Health International, involving 1,700 women in Nigeria, was stopped as a precaution although no increased risk of infection has been seen.

MORE FROM AIDS

AIDS Section Front

New hope on AIDS in Africa   Key to HIV shot may be body’s initial reaction   Bush, first lady mark World AIDS Day Global AIDS crisis overblown? Some dare to say so Math model: HIV can be eliminated in a decade Some AIDS patients face microchip monitoring AIDS official blasts Russia as infections rise Lawsuit claims teen with HIV was bullied HIV tests not as routine as government wants Marrow transplant may have cured man’s AIDS AIDS Section Front   Add AIDS headlines to your news reader: